Cerus Corp (CERS) stock
CERSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 6/3027% below fair value
$1.94−0.18 (-8.49%)
Close on Nov 12, 2026Market cap $390.96MP/E –Yield –
Cerus r&d expenses
Research and development expenses are spending on new products and technology.
Cerus's R&D Expenses for the twelve months ending Sep 30, 2026 was $59.58M, down 10.8% year over year. For fiscal 2025 it was $67.72M, up 15.0% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $67.72M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.72M | +15.0% |
| FY2024 | Dec 31, 2024 | $58.91M | -12.9% |
| FY2023 | Dec 31, 2023 | $67.64M | +5.5% |
| FY2022 | Dec 31, 2022 | $64.11M | +0.7% |
| FY2021 | Dec 31, 2021 | $63.69M | -1.1% |
| FY2020 | Dec 31, 2020 | $64.41M | +6.7% |
| FY2019 | Dec 31, 2019 | $60.38M | +41.8% |
| FY2018 | Dec 31, 2018 | $42.56M | +26.3% |
| FY2017 | Dec 31, 2017 | $33.71M | +7.6% |
| FY2016 | Dec 31, 2016 | $31.32M | +22.1% |
| FY2015 | Dec 31, 2015 | $25.64M | +17.6% |
| FY2014 | Dec 31, 2014 | $21.80M | +43.5% |
| FY2013 | Dec 31, 2013 | $15.19M | +99.8% |
| FY2012 | Dec 31, 2012 | $7.60M | +5.9% |
| FY2011 | Dec 31, 2011 | $7.18M | +38.2% |
| FY2010 | Dec 31, 2010 | $5.20M | -18.5% |
| FY2009 | Dec 31, 2009 | $6.37M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $14.27M | -9.8% |
| Q2 FY2026 | Jun 30, 2026 | $14.39M | -23.9% |
| Q1 FY2026 | Mar 31, 2026 | $14.53M | -12.5% |
| Q4 FY2025 | Dec 31, 2025 | $16.39M | +6.1% |
| Q3 FY2025 | Sep 30, 2025 | $15.83M | +12.9% |
| Q2 FY2025 | Jun 30, 2025 | $18.90M | +26.3% |
| Q1 FY2025 | Mar 31, 2025 | $16.61M | +14.7% |
| Q4 FY2024 | Dec 31, 2024 | $15.44M | +8.1% |
| Q3 FY2024 | Sep 30, 2024 | $14.01M | -16.5% |
| Q2 FY2024 | Jun 30, 2024 | $14.97M | -22.0% |
| Q1 FY2024 | Mar 31, 2024 | $14.48M | -16.7% |
| Q4 FY2023 | Dec 31, 2023 | $14.29M | -23.2% |
| Q3 FY2023 | Sep 30, 2023 | $16.78M | +3.5% |
| Q2 FY2023 | Jun 30, 2023 | $19.18M | +26.1% |
| Q1 FY2023 | Mar 31, 2023 | $17.38M | +23.7% |
| Q4 FY2022 | Dec 31, 2022 | $18.61M | +19.5% |
| Q3 FY2022 | Sep 30, 2022 | $16.22M | +6.1% |
| Q2 FY2022 | Jun 30, 2022 | $15.22M | -10.9% |
| Q1 FY2022 | Mar 31, 2022 | $14.06M | -10.7% |
| Q4 FY2021 | Dec 31, 2021 | $15.57M | -8.7% |
| Q3 FY2021 | Sep 30, 2021 | $15.29M | -4.0% |
| Q2 FY2021 | Jun 30, 2021 | $17.08M | +9.4% |
| Q1 FY2021 | Mar 31, 2021 | $15.75M | -0.4% |
| Q4 FY2020 | Dec 31, 2020 | $17.06M | +3.8% |
| Q3 FY2020 | Sep 30, 2020 | $15.92M | -1.0% |
| Q2 FY2020 | Jun 30, 2020 | $15.62M | +8.3% |
| Q1 FY2020 | Mar 31, 2020 | $15.81M | +17.6% |
| Q4 FY2019 | Dec 31, 2019 | $16.44M | +32.3% |
| Q3 FY2019 | Sep 30, 2019 | $16.08M | +48.6% |
| Q2 FY2019 | Jun 30, 2019 | $14.42M | +45.9% |
| Q1 FY2019 | Mar 31, 2019 | $13.44M | +42.4% |
| Q4 FY2018 | Dec 31, 2018 | $12.42M | +59.6% |
| Q3 FY2018 | Sep 30, 2018 | $10.83M | +37.3% |
| Q2 FY2018 | Jun 30, 2018 | $9.88M | +11.1% |
| Q1 FY2018 | Mar 31, 2018 | $9.44M | +3.1% |
| Q4 FY2017 | Dec 31, 2017 | $7.78M | -11.7% |
| Q3 FY2017 | Sep 30, 2017 | $7.89M | – |
| Q2 FY2017 | Jun 30, 2017 | $8.89M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.15M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.82M | – |
See a number that looks wrong?